Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Other financing activities (2018 - 2025)

Historic Other financing activities for Neuronetics (STIM) over the last 7 years, with Q3 2025 value amounting to -$1.7 million.

  • Neuronetics' Other financing activities changed N/A to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $516000.0, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2024, which is 13768.12% up from last year.
  • As of Q3 2025, Neuronetics' Other financing activities stood at -$1.7 million.
  • Neuronetics' 5-year Other financing activities high stood at $1.7 million for Q1 2025, and its period low was -$1.7 million during Q3 2025.
  • Moreover, its 5-year median value for Other financing activities was $151500.0 (2023), whereas its average is $211200.0.
  • In the last 5 years, Neuronetics' Other financing activities plummeted by 8578.55% in 2022 and then soared by 2400000.0% in 2023.
  • Quarter analysis of 5 years shows Neuronetics' Other financing activities stood at $401000.0 in 2021, then tumbled by 99.75% to $1000.0 in 2022, then soared by 24000.0% to $241000.0 in 2023, then skyrocketed by 80.91% to $436000.0 in 2024, then plummeted by 478.67% to -$1.7 million in 2025.
  • Its Other financing activities was -$1.7 million in Q3 2025, compared to $1.7 million in Q1 2025 and $436000.0 in Q4 2024.